Intracerebral hemorrhage specific intensity of care quality metrics

Neurocritical Care

Volumn 14, Issue 2, 2011, Pages 291-317

  Qureshi, Adnan I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cerebral hemorrhage; Intensity of care; Intensive care unit; Intracerebral hemorrhage; Quality indicators

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; BLOOD CLOTTING FACTOR 7A; CANDESARTAN; DIAZEPAM; ENOXAPARIN; ETIRACETAM; FOSPHENYTOIN SODIUM; FRESH FROZEN PLASMA; GLUCOSE; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; INSULIN; LORAZEPAM; LOW MOLECULAR WEIGHT HEPARIN; MANNITOL; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; PLACEBO; PROTHROMBIN COMPLEX; RANITIDINE; SODIUM CHLORIDE; SUCRALFATE; VITAMIN K GROUP;

ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; BRAIN HERNIA; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DRUG CHOICE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG MEGADOSE; DYSPHAGIA; EMERGENCY WARD; ENTERIC FEEDING; EPILEPTIC STATE; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; GLUCOSE BLOOD LEVEL; HEALTH CARE QUALITY; HUMAN; HYPERPYREXIA; HYPERTENSION; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HYPERTENSION; LOW DRUG DOSE; LUNG EMBOLISM; MEDICAL DOCUMENTATION; NEUROIMAGING; NUTRITIONAL SUPPORT; PILOT STUDY; PRIORITY JOURNAL; REVIEW; SEIZURE; STANDARDIZATION; STOMACH ULCER; SURGICAL DRAINAGE; SYSTOLIC BLOOD PRESSURE; TRACHEOSTOMY; VENTILATOR ASSOCIATED PNEUMONIA;

CEREBRAL HEMORRHAGE; EVIDENCE-BASED MEDICINE; HUMANS; INTENSIVE CARE; QUALITY OF HEALTH CARE;

EID: 79955805142     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-010-9453-z     Document Type: Review

References (206)

1. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29: 635-40. (Pubitemid 32225309)
2. Qureshi AI, Suri MFK, Nasar A, et al. Changes in cost and outcome among US patients with stroke hospitalized in 1990 to 1991 and those hospitalized in 2000 to 2001. Stroke. 2007;38: 2180-4. (Pubitemid 47012287)
3. Wentworth DA, Atkinson RP. Implementation of an acute stroke program decreases hospitalization costs and length of stay. Stroke. 1996;27:1040-3. (Pubitemid 26177603)
4. Suarez JI, Zaidat OO, Suri MF, et al. Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit Care Med. 2004;32:2311-7. (Pubitemid 39491814)
5. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2007:CD000197.
6. Clifton GL, Choi SC, Miller ER, et al. Intercenter variance in clinical trials of head trauma-experience of the National Acute Brain Injury Study: hypothermia. J Neurosurg. 2001;95:751-5. (Pubitemid 33043346)
7. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387-97. (Pubitemid 40179225)
8. Narayan RK, Michel ME, Ansell B, et al. Clinical trials in head injury. J Neurotrauma. 2002;19:503-57. (Pubitemid 34587299)
9. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/ American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38:2001-23. (Pubitemid 46850654)
10. Steiner T, Kaste M, Forsting M, et al. Recommendations for the management of intracranial haemorrhage-part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis. 2006;22:294-316.
11. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373:1632-44.
12. Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA. 2000;283:3102-9. (Pubitemid 30399721)
13. Adams HPJ, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-711. (Pubitemid 46691097)
14. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Stroke. 1997;28:1530-40.
15. Wattigney WA, Croft JB, Mensah GA, et al. Establishing data elements for the Paul Coverdell National Acute Stroke Registry: Part 1: proceedings of an expert panel. Stroke. 2003;34:151-6. (Pubitemid 36070816)
16. Mohammad Y. Mode of arrival to the emergency department of stroke patients in the United States. J Vasc Interv Neurol. 2008;1:83-6.
17. Jacobs BS, Birbeck G, Mullard AJ, et al. Quality of hospital care in African American and white patients with ischemic stroke and TIA. Neurology. 2006;66:809-14. (Pubitemid 43739752)
18. Rodriguez GJ, Nasar A, Suri MFK, Ezzeddine MA, Qureshi AI. Neuroimaging in stroke and seizure as neurological emergencies (NISSAN) study. J Neuroimaging. 2008;18:9-14.
19. http://www.ninds.nih.gov/news-and-events/proceedings/stroke- proceedings/execsum.htm. Accessed 9 Sept 2010.
20. Wojner AW, Morgenstern L, Alexandrov AV, et al. Paramedic and emergency department care of stroke: baseline data from a citywide performance improvement study. Am J Crit Care. 2003;12:411-7.
21. Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation. 2008;118:176-87.
22. Prehospital and hospital delays after stroke onset-United States, 2005-2006. MMWR Morb Mortal Wkly Rep. 2007;56: 474-8.
23. Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S. Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey. Stroke. 2000;31: 2585-90.
24. Evenson KR, Foraker RE, Morris DL, Rosamond WD. A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke. 2009;4:187-99.
25. Smith EE, Liang L, Hernandez A, et al. Influence of stroke subtype on quality of care in the Get With The Guidelines- Stroke Program. Neurology. 2009;73:709-16.
26. Morgan T, Awad I, Keyl P, Lane K, Hanley D. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl. 2008;105:217-20.
27. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450-60. (Pubitemid 32402103)
28. Qureshi AI, Safdar K, Weil J, et al. Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke. 1995;26:1764-7.
29. Leira R, Davalos A, Silva Y, et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology. 2004;63:461-7. (Pubitemid 39031375)
30. ATACH investigators. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med. 2010;38:637-48.
31. Penny JA, Shennan AH, Halligan AW, et al. The relative accuracy of sequential same-arm and simultaneous opposite-arm measurements for the intra-arterial validation of blood pressure monitors. Blood Press Monit. 1999;4:91-5. (Pubitemid 29467111)
32. Manolio TA, Fishel SC, Beattie C, et al. Evaluation of the Dinamap continuous blood pressure monitor. Am J Hypertens. 1988;1:161S-7S.
33. Qureshi AI, Bliwise DL, Bliwise NG, et al. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med. 1999;27:480-5. (Pubitemid 29162666)
34. Hemphill JC 3rd, White DB. Clinical nihilism in neuroemergencies. Emerg Med Clin N Am. 2009;27:27-37. (vii-37, vii-viii).
35. Zimmerman JE, Knaus WA, Sharpe SM, et al. The use and implications of do not resuscitate orders in intensive care units. JAMA. 1986;255:351-6. (Pubitemid 16146696)
36. Smedira NG, Evans BH, Grais LS, et al. Withholding and withdrawal of life support from the critically ill. N Engl J Med. 1990;322:309-15. (Pubitemid 20046334)
37. Zurasky JA, Aiyagari V, Zazulia AR, Shackelford A, Diringer MN. Early mortality following spontaneous intracerebral hemorrhage. Neurology. 2005;64:725-7. (Pubitemid 40261908)
38. Becker KJ, Baxter AB, Cohen WA, et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology. 2001;56:766-72. (Pubitemid 32240097)
39. Ethical and moral guidelines for the initiation, continuation, and withdrawal of intensive care. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Panel. Chest. 1990;97:949-58.
40. Hemphill JC 3rd, Newman J, Zhao S, Johnston SC. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke. 2004;35:1130-4. (Pubitemid 38543531)
41. Zahuranec DB, Brown DL, Lisabeth LD, et al. Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology. 2007;68:1651-7. (Pubitemid 46763251)
42. Alexandrov AV, Bladin CF, Meslin EM, Norris JW. Do-notresuscitate orders in acute stroke. Neurology. 1995;45:634-40.
43. Alexandrov AV, Pullicino PM, Meslin EM, Norris JW. Agreement on disease-specific criteria for do-not-resuscitate orders in acute stroke. Members of the Canadian and Western New York Stroke Consortiums. Stroke. 1996;27:232-7. (Pubitemid 26044492)
44. Qureshi AI, Ezzeddine MA, Nasar A, et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25:32-8. (Pubitemid 44869006)
45. Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke. 1997;28:2370-5. (Pubitemid 28007634)
46. Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke. 1995;26:21-4.
47. Vemmos KN, Tsivgoulis G, Spengos K, et al. Association between 24-h blood pressure monitoring variables and brain oedema in patients with hyperacute stroke. J Hypertens. 2003; 21:2167-73. (Pubitemid 38296879)
48. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391-9.
49. Qureshi AI, Palesch YY, Martin R, et al. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch Neurol. 2010;67:570-6.
50. Kim-Han JS, Kopp SJ, Dugan LL, Diringer MN. Perihematomal mitochondrial dysfunction after intracerebral hemorrhage. Stroke. 2006;37:2457-62. (Pubitemid 44454660)
51. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001;57:18-24. (Pubitemid 32634845)
52. Qureshi AI, Harris-Lane P, Kirmani JF, et al. Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines. Crit Care Med. 2006; 34:1975-80. (Pubitemid 43982476)
53. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996;27:1783-7. (Pubitemid 26332505)
54. Morfis L, Schwartz RS, Poulos R, Howes LG. Blood pressure changes in acute cerebral infarction and hemorrhage. Stroke. 1997;28:1401-5. (Pubitemid 27300678)
55. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5. (Pubitemid 27039454)
56. Mayer SA, Sacco RL, Shi T, Mohr JP. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology. 1994;44:1379-84. (Pubitemid 24247421)
57. Qureshi AI. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH): rationale and design. Neurocrit Care. 2007;6:56-66. (Pubitemid 46424454)
58. Gujjar AR, Deibert E, Manno EM, Duff S, Diringer MN. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology. 1998; 51:447-51. (Pubitemid 28406320)
59. Bushnell CD, Phillips-Bute BG, Laskowitz DT, et al. Survival and outcome after endotracheal intubation for acute stroke. Neurology. 1999;52:1374-81. (Pubitemid 29190526)
60. Cummins RO, Chamberlain D, Hazinski MF, et al. Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. American Heart Association. Circulation. 1997;95:2213-39.
61. Wong ML, Carey S, Mader TJ, Wang HE. Time to invasive airway placement and resuscitation outcomes after inhospital cardiopulmonary arrest. Resuscitation. 2010;81:182-6.
62. Shy BD, Rea TD, Becker LJ, Eisenberg MS. Time to intubation and survival in prehospital cardiac arrest. Prehosp Emerg Care. 2004;8:394-9. (Pubitemid 39298756)
63. Wirth A, Baethmann A, Schlesinger-Raab A, et al. Prospective documentation and analysis of the pre- and early clinical management in severe head injury in southern Bavaria at a population based level. Acta Neurochir Suppl. 2004;89:119-23.
64. Davis DP, Idris AH, Sise MJ, et al. Early ventilation and outcome in patients with moderate to severe traumatic brain injury. Crit Care Med. 2006;34:1202-8.
65. Gentleman D. Causes and effects of systemic complications among severely head injured patients transferred to a neurosurgical unit. Int Surg. 1992;77:297-302.
66. Stauffer JL, Olson DE, Petty TL. Complications and consequences of endotracheal intubation and tracheotomy. A prospective study of 150 critically ill adult patients. Am J Med. 1981; 70:65-76. (Pubitemid 11183518)
67. Bobrow BJ, Clark LL, Ewy GA, et al. Minimally interrupted cardiac resuscitation by emergency medical services for out-ofhospital cardiac arrest. JAMA. 2008;299:1158-65. (Pubitemid 351398430)
68. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33:136-40. (Pubitemid 34055759)
69. Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke. 1998;29:1550-5. (Pubitemid 28365572)
70. Osborn AG. The medical tentorium and incisura: normal and pathological anatomy. Neuroradiology. 1977;13:109-13. (Pubitemid 8085090)
71. Nemecek S. On the pathogenesis of occipital infarction in transtentorial herniation of the brain. Pathological-anatomical study. Zentralbl Allg Pathol. 1961;102:138-42.
72. Ropper AH. Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N Engl J Med. 1986;314:953-8. (Pubitemid 16129830)
73. Qureshi AI, Geocadin RG, Suarez JI, Ulatowski JA. Long-term outcome after medical reversal of transtentorial herniation in patients with supratentorial mass lesions. Crit Care Med. 2000;28:1556-64. (Pubitemid 30324539)
74. Qureshi AI, Wilson DA, Traystman RJ. Treatment of transtentorial herniation unresponsive to hyperventilation using hypertonic saline in dogs: effect on cerebral blood flow and metabolism. J Neurosurg Anesthesiol. 2002;14:22-30. (Pubitemid 34027696)
75. Qureshi AI, Suarez JI. More evidence supporting a ''brain code'' protocol for reversal of transtentorial herniation. Neurology. 2008;70:990-1. (Pubitemid 351451325)
76. Andrews BT, Pitts LH. Functional recovery after traumatic transtentorial herniation. Neurosurgery. 1991;29:227-31.
77. Nussbaum ES, Wolf AL, Sebring L, Mirvis S. Complete temporal lobectomy for surgical resuscitation of patients with transtentorial herniation secondary to unilateral hemispheric swelling. Neurosurgery. 1991;29:62-6.
78. Noppens RR, Christ M, Brambrink AM, et al. An early bolus of hypertonic saline hydroxyethyl starch improves long-term outcome after global cerebral ischemia. Crit Care Med. 2006;34: 2194-200. (Pubitemid 44305625)
79. Koenig MA, Bryan M, Lewin JL. Reversal of transtentorial herniation from supratentorial lesions with 23.4% saline. Neurology. 2008;70:1023-9. (Pubitemid 351451321)
80. Vialet R, Albanese J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med. 2003;31:1683-7. (Pubitemid 36714221)
81. Misra UK, Kalita J, Ranjan P, Mandal SK. Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci. 2005;234:41-5. (Pubitemid 40910342)
82. Kalita J, Misra UK, Ranjan P, Pradhan PK, Das BK. Effect of mannitol on regional cerebral blood flow in patients with intracerebral hemorrhage. J Neurol Sci. 2004;224:19-22. (Pubitemid 39278257)
83. Bereczki D, Liu M, Prado GF, Fekete I. Cochrane report: a systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage. Stroke. 2000;31:2719-22.
84. Fernandes HM, Siddique S, Banister K, et al. Continuous monitoring of ICP and CPP following ICH and its relationship to clinical, radiological and surgical parameters. Acta Neurochir Suppl. 2000;76:463-6.
85. Broderick JP, Adams HPJ, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1999;30:905-15. (Pubitemid 29156390)
86. Janny P, Papo I, Chazal J, Colnet G, Barretto LC. Intracranial hypertension and prognosis of spontaneous intracerebral haematomas. A correlative study of 60 patients. Acta Neurochir (Wien). 1982;61:181-6. (Pubitemid 12161085)
87. Papo I, Janny P, Caruselli G, Colnet G, Luongo A. Intracranial pressure time course in primary intracerebral hemorrhage. Neurosurgery. 1979;4:504-11. (Pubitemid 10232009)
88. Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43:1175-80. (Pubitemid 35176125)
89. Vespa PM, O'Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003;60:1441-6. (Pubitemid 36554803)
90. Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62: 1743-8. (Pubitemid 38661728)
91. Legriel S, Mourvillier B, Bele N, et al. Outcomes in 140 critically ill patients with status epilepticus. Intensive Care Med. 2008;34:476-80.
92. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-ofhospital status epilepticus. N Engl J Med. 2001;345:631-7.
93. Mercade-Cerda JM, Sanchez-Alvarez JC, Galan-Barranco JM, et al. Consensus clinical practice guidelines of the Andalusian Epilepsy Society: therapeutic recommendations when dealing with a first epileptic seizure and in epileptic status. Rev Neurol. 2009;48:489-95.
94. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339:792-8. (Pubitemid 28447452)
95. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA. 1993;270:854-9.
96. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993;43:483-8. (Pubitemid 23088478)
97. Varelas PN, Mirski MA. Management of seizures in critically ill patients. Curr Neurol Neurosci Rep. 2004;4:489-96. (Pubitemid 39585752)
98. Lawn ND, Wijdicks EFM. Progress in clinical neurosciences: status epilepticus: a critical review of management options. Can J Neurol Sci. 2002;29:206-15. (Pubitemid 34966314)
99. Cock HR, Schapira AHV. A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. QJM. 2002;95:225-31.
100. Claassen J, Hirsch LJ, Mayer SA. Treatment of status epilepticus: a survey of neurologists. J Neurol Sci. 2003;211:37-41. (Pubitemid 36593265)
101. Kalviainen R. Status epilepticus treatment guidelines. Epilepsia. 2007;48(Suppl 8):99-102. (Pubitemid 350045540)
102. Moddel G, Bunten S, Dobis C, et al. Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus. J Neurol Neurosurg Psychiatry. 2009;80:689-92.
103. Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke. 2006;37:256-62. (Pubitemid 43732088)
104. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet. 1996;348:423-8. (Pubitemid 26267872)
105. Kase CS, Robinson RK, Stein RW, et al. Anticoagulant-related intracerebral hemorrhage. Neurology. 1985;35:943-8. (Pubitemid 15026263)
106. Franke CL, de Jonge J, van Swieten JC, Op de Coul AA, van Gijn J. Intracerebral hematomas during anticoagulant treatment. Stroke. 1990;21:726-30. (Pubitemid 20180795)
107. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059-64. (Pubitemid 39287915)
108. Sjoblom L, Hardemark HG, Lindgren A, et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke. 2001;32: 2567-74. (Pubitemid 33055307)
109. Baker RI, Coughlin PB, Gallus AS, et al. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust. 2004;181:492-7. (Pubitemid 39534470)
110. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004; 164:880-4. (Pubitemid 38520629)
111. Huttner HB, Schellinger PD, Hartmann M, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006;37:1465-70. (Pubitemid 44305727)
112. Goldstein JN, Thomas SH, Frontiero V, et al. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke. 2006;37:151-5. (Pubitemid 43732064)
113. Rabinstein AA, Wijdicks EFM. Determinants of outcome in anticoagulation-associated cerebral hematoma requiring emergency evacuation. Arch Neurol. 2007;64:203-6.
114. Roitberg B, Emechebe-Kennedy O, Amin-Hanjani S, Mucksavage J, Tesoro E. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study. Neurosurgery. 2005;57:832-6.
115. Freeman WD, Brott TG, Barrett KM, et al. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc. 2004;79:1495-500. (Pubitemid 39578872)
116. Brody DL, Aiyagari V, Shackleford AM, Diringer MN. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit Care. 2005;2:263-7. (Pubitemid 41112397)
117. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127-37. (Pubitemid 351679599)
118. Broderick JP, Diringer MN, Hill MD, et al. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke. 2007;38:1072-5. (Pubitemid 46568477)
119. Lee S-H, Kim BJ, Bae H-J, et al. Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study. Diabetologia. 2010;53: 429-34.
120. Kreisel SH, Berschin UM, Hammes H-P, et al. Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovasc Dis. 2009;27:167-75.
121. Adams HPJ, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056-83. (Pubitemid 36402991)
122. Meijering S, Corstjens AM, Tulleken JE, et al. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care. 2006;10:R19.
123. McCormick MT, Muir KW, Gray CS, Walters MR. Management of hyperglycemia in acute stroke: how, when, and for whom? Stroke. 2008;39:2177-85.
124. Passero S, Ciacci G, Ulivelli M. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology. 2003;61:1351-6. (Pubitemid 37463369)
125. Woo J, Lam CW, Kay R, et al. The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol. 1990;47:1174-7. (Pubitemid 20380994)
126. Godoy DA, Pinero GR, Svampa S, Papa F, Di Napoli M. Hyperglycemia and short-term outcome in patients with spontaneous intracerebral hemorrhage. Neurocrit Care. 2008;9:217-29.
127. Ho CL, Ang CBT, Lee KK, Ng IHB. Effects of glycaemic control on cerebral neurochemistry in primary intracerebral haemorrhage. J Clin Neurosci. 2008;15:428-33.
128. Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassium- insulin infusions in the management of post-stroke hyperglycaemia: The UK Glucose Insulin in Stroke Trial (GISTUK). Lancet Neurol. 2007;6:397-406. (Pubitemid 46551852)
129. DuBose JJ, Nomoto S, Higa L, et al. Nursing involvement improves compliance with tight blood glucose control in the trauma ICU: a prospective observational study. Intensive Crit Care Nurs. 2009;25:101-7.
130. Johnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR. Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. Stroke. 2009;40:3804-9.
131. Bruno A, Kent TA, Coull BM, et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke. 2008;39:384-9.
132. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
133. Hendra TJ, Yudkin JS. An algorithm for tight glycaemic control in diabetic infarct survivors. Diabetes Res Clin Pract. 1992;16: 213-20.
134. Gray CS, Hildreth AJ, Alberti GKMM, O'Connell JE. Poststroke hyperglycemia: natural history and immediate management. Stroke. 2004;35:122-6. (Pubitemid 38057604)
135. Zubkov AY, Mandrekar JN, Claassen DO, et al. Predictors of outcome in warfarin-related intracerebral hemorrhage. Arch Neurol. 2008;65:1320-5.
136. Walters MR, Weir CJ, Lees KR. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis. 2006;22:116-22. (Pubitemid 44114452)
137. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354:449-61. (Pubitemid 43200296)
138. Reith J, Jorgensen HS, Pedersen PM, et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet. 1996;347:422-5. (Pubitemid 26054066)
139. Mayer SA, Kowalski RG, Presciutti M, et al. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med. 2004;32:2508-15. (Pubitemid 39648236)
140. Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54:354-61. (Pubitemid 30078066)
141. den Hertog HM, van der Worp HB, van Gemert HMA, et al. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol. 2009;8:434-40.
142. Walson PD, Jones J, Chesney R, Rodarte A. Antipyretic efficacy and tolerability of a single intravenous dose of the acetaminophen prodrug propacetamol in children: a randomized, doubleblind, placebo-controlled trial. Clin Ther. 2006;28:762-9. (Pubitemid 44173052)
143. Bachert C, Chuchalin AG, Eisebitt R, Netayzhenko VZ, Voelker M. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour doseranging study. Clin Ther. 2005;27:993-1003. (Pubitemid 41262457)
144. Diringer MN. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med. 2004;32:559-64. (Pubitemid 38234141)
145. Dippel DWJ, van Breda EJ, van der Worp HB, et al. Timing of the effect of acetaminophen on body temperature in patients with acute ischemic stroke. Neurology. 2003;61:677-9. (Pubitemid 37082605)
146. Ogata T, Yasaka M, Wakugawa Y, et al. Deep venous thrombosis after acute intracerebral hemorrhage. J Neurol Sci. 2008; 272:83-6.
147. Boeer A, Voth E, Henze T, Prange HW. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1991;54:466-7.
148. Lacut K, Bressollette L, Le Gal G, et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology. 2005;65:865-9. (Pubitemid 41362131)
149. Tetri S, Hakala J, Juvela S, et al. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage. Thromb Res. 2008;123: 206-12.
150. Orken DN, Kenangil G, Ozkurt H, et al. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Neurologist. 2009;15:329-31.
151. Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Clin Ther. 2007;29:2395-405.
152. Kamphuisen PW, Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thromb Res. 2007;119:265-74. (Pubitemid 44920433)
153. Guyomard V, Fulcher RA, Redmayne O, et al. Effect of dysphasia and dysphagia on inpatient mortality and hospital length of stay: a database study. J Am Geriatr Soc. 2009;57:2101-6.
154. Warnecke T, Ritter MA, Kroger B, et al. Fiberoptic endoscopic dysphagia severity scale predicts outcome after acute stroke. Cerebrovasc Dis. 2009;28:283-9.
155. Martino R, Pron G, Diamant N. Screening for oropharyngeal dysphagia in stroke: insufficient evidence for guidelines. Dysphagia. 2000;15:19-30. (Pubitemid 30040587)
156. LaBresh KA, Reeves MJ, Frankel MR, Albright D, Schwamm LH. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the ''Get With The Guidelines'' program. Arch Intern Med. 2008;168:411-7. (Pubitemid 351347133)
157. George MG, Tong X, McGruder H, et al. Paul Coverdell National Acute Stroke Registry Surveillance-four states, 2005- 2007. MMWR Surveill Summ. 2009;58:1-23.
158. Reeves MJ, Broderick JP, Frankel M, et al. The Paul Coverdell National Acute Stroke Registry: initial results from four prototypes. Am J Prev Med. 2006;31:S202-9. (Pubitemid 44908856)
159. Trapl M, Enderle P, Nowotny M, et al. Dysphagia bedside screening for acute-stroke patients: the gugging swallowing screen. Stroke. 2007;38:2948-52. (Pubitemid 350035688)
160. Lim SH, Lieu PK, Phua SY, et al. Accuracy of bedside clinical methods compared with fiberoptic endoscopic examination of swallowing (FEES) in determining the risk of aspiration in acute stroke patients. Dysphagia. 2001;16:1-6. (Pubitemid 32259781)
161. Martino R, Silver F, Teasell R, et al. The Toronto Bedside Swallowing Screening Test (TOR-BSST): development and validation of a dysphagia screening tool for patients with stroke. Stroke. 2009;40:555-61.
162. Perry L, Love CP. Screening for dysphagia and aspiration in acute stroke: a systematic review. Dysphagia. 2001;16:7-18. (Pubitemid 32259782)
163. Souba WW. Nutritional support. N Engl J Med. 1997;336:41-8. (Pubitemid 26428286)
164. Finestone HM, Greene-Finestone LS, Wilson ES, Teasell RW. Prolonged length of stay and reduced functional improvement rate in malnourished stroke rehabilitation patients. Arch Phys Med Rehabil. 1996;77:340-5. (Pubitemid 26111748)
165. Davis JP, Wong AA, Schluter PJ, et al. Impact of premorbid undernutrition on outcome in stroke patients. Stroke. 2004; 35:1930-4. (Pubitemid 38971878)
166. Nyswonger GD, Helmchen RH. Early enteral nutrition and length of stay in stroke patients. J Neurosci Nurs. 1992;24: 220-3.
167. Dennis MS, Lewis SC, Warlow C. Routine oral nutritional supplementation for stroke patients in hospital (FOOD): a multicentre randomised controlled trial. Lancet. 2005;365: 755-63.
168. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med. 1998;338:791-7. (Pubitemid 28135985)
169. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA. 1996;275:308-14.
170. Erstad BL, Camamo JM, Miller MJ, Webber AM, Fortune J. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center. Crit Care Med. 1997;25:1678-84. (Pubitemid 27435503)
171. Misra UK, Kalita J, Pandey S, Mandal SK, Srivastava M. A randomized placebo controlled trial of ranitidine versus sucralfate in patients with spontaneous intracerebral hemorrhage for prevention of gastric hemorrhage. J Neurol Sci. 2005;239: 5-10. (Pubitemid 41617409)
172. Eddleston JM, Pearson RC, Holland J, et al. Prospective endoscopic study of stress erosions and ulcers in critically ill adult patients treated with either sucralfate or placebo. Crit Care Med. 1994;22:1949-54. (Pubitemid 24375096)
173. Apte NM, Karnad DR, Medhekar TP, et al. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med. 1992;20:590-3.
174. Lu WY, Rhoney DH, Boling WB, Johnson JD, Smith TC. A review of stress ulcer prophylaxis in the neurosurgical intensive care unit. Neurosurgery. 1997;41:416-25. (discussion 425-4125; discussion 425-6).
175. Hatton J, Lu WY, Rhoney DH, et al. A step-wise protocol for stress ulcer prophylaxis in the neurosurgical intensive care unit. Surg Neurol. 1996;46:493-9. (Pubitemid 26353493)
176. Farrell CP, Mercogliano G, Kuntz CL. Overuse of stress ulcer prophylaxis in the critical care setting and beyond. J Crit Care. 2010;25:214-20.
177. Ovbiagele B, Hills NK, Saver JL, Johnston SC. Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event. Stroke. 2005;36:1944-7. (Pubitemid 41266532)
178. Gueyffier F, Boissel JP, Boutitie F, et al. Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. Stroke. 1997;28:2557-62. (Pubitemid 28007667)
179. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-41.
180. Rezaiefar P, Pottie K. Blood pressure and secondary prevention of strokes. How low should we go? Randomised trial of a perindopril- based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Can Fam Physician. 2002;48:1625-9.
181. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation. 2006;113:e409-49. (Pubitemid 43739468)
182. Schrader J, Luders S, Kulschewski A, et al. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke. 2003;34:1699-703. (Pubitemid 36842630)
183. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-72. (Pubitemid 37430158)
184. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003; 42:1206-52. (Pubitemid 37553153)
185. Ivatury R, Siegel JH, Stahl WM, et al. Percutaneous tracheostomy after trauma and critical illness. J Trauma. 1992;32:133-40.
186. Shirawi N, Arabi Y. Bench-to-bedside review: early tracheostomy in critically ill trauma patients. Crit Care. 2006;10:201.
187. Qureshi AI, Suarez JI, Parekh PD, Bhardwaj A. Prediction and timing of tracheostomy in patients with infratentorial lesions requiring mechanical ventilatory support. Crit Care Med. 2000; 28:1383-7. (Pubitemid 30324510)
188. Ahmed N, Kuo Y-H. Early versus late tracheostomy in patients with severe traumatic head injury. Surg Infect (Larchmt). 2007; 8:343-7. (Pubitemid 47186304)
189. Sugerman HJ, Wolfe L, Pasquale MD, et al. Multicenter, randomized, prospective trial of early tracheostomy. J Trauma. 1997; 43:741-7. (Pubitemid 27513741)
190. Griffiths J, Barber VS, Morgan L, Young JD. Systematic review and meta-analysis of studies of the timing of tracheostomy in adult patients undergoing artificial ventilation. BMJ. 2005;330: 1243.
191. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
192. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med. 1996;153:1711-25.
193. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med. 1999;159:1249-56. (Pubitemid 29202563)
194. Maramattom BV, Weigand S, Reinalda M, Wijdicks EFM, Manno EM. Pulmonary complications after intracerebral hemorrhage. Neurocrit Care. 2006;5:115-9. (Pubitemid 44729636)
195. Christensen MC, Previgliano I, Capparelli FJ, et al. Acute treatment costs of intracerebral hemorrhage and ischemic stroke in Argentina. Acta Neurol Scand. 2009;119:246-53.
196. Heyland DK, Dodek P, Muscedere J, et al. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med. 2008; 36:737-44.
197. Chastre J, Wolff M, Fagon J-Y, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290:2588-98. (Pubitemid 37443289)
198. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002;122: 262-8. (Pubitemid 34754172)
199. Mathevon T, Souweine B, Traore O, Aublet B, Caillaud D. ICUacquired nosocomial infection: impact of delay of adequate antibiotic treatment. Scand J Infect Dis. 2002;34:831-5. (Pubitemid 36124483)
200. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med. 1996;22:387-94. (Pubitemid 26174308)
201. Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med. 2001;27: 355-62. (Pubitemid 32249978)
202. Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley; 1981.
203. Hoff G, Ottestad PM, Skaflotten SR, Bretthauer M, Moritz V. Quality assurance as an integrated part of the electronic medical record-a prototype applied for colonoscopy. Scand J Gastroenterol. 2009;44:1259-65.
204. Maset AL, Marmarou A, Ward JD, et al. Pressure-volume index in head injury. J Neurosurg. 1987;67:832-40. (Pubitemid 18005527)
205. Marmarou A, Nichols J, Burgess J, et al. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group. J Neurotrauma. 1999;16:431-44. (Pubitemid 29297899)
206. Miranda DR, de Rijk A, Schaufeli W. Simplified Therapeutic Intervention Scoring System: the TISS-28 items-results from a multicenter study. Crit Care Med. 1996;24:64-73.